Navigation Links
Genmab Announces 2008 First Half Year Results
Date:8/27/2008

articipated in the ongoing Phase III NHL study.

4) Phase I study in Japan. The primary objective of the study is to evaluate the safety and tolerability of ofatumumab in Japanese relapsed/refractory follicular NHL and CLL patients.

We completed recruitment of 56 patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat CLL in previously untreated patients.

Amgen informed Genmab that it would discontinue development for AMG714 in psoriasis and RA based on disappointing results from recent clinical studies. Amgen is exploring options to maximize the value of this asset, but at this time no further internal development of a lead indication is planned.

Outlook

Genmab is maintaining its financial guidance for the net loss in 2008 in the range of DKK 800 to 900 million and projects a slightly improved operating loss of DKK 850 to 950 million compared to previous guidance of DKK 900 to 1,000 million. This is despite a lower revenue estimate, which is now anticipated to be in the range of DKK 850 to 900 million due to a slight change in the timing of some anticipated milestone events and lower net financial income which is now expected to be DKK 40 to 50 million. The savings are driven by a reduction in our research and development costs which is a result of our efforts to focus on the most critical programs in our portfolio in the most efficient manner. We therefore currently anticipate that we will start fewer new studies in 2008 than the 17 previously planned.

As of December 31, 2007, Genmab had cash, cash equivalents and short-term marketable securities of DKK 3.7 billion. For 2008, we project that our operations together with the DKK 1.2 billion acquisition of the manufacturing facility in Minnesota will lead to a year end cash position of DKK 1.7 to 1.8 billion (USD 359 million to USD 380 million), unchanged from previous guidance. The proportion of the budget spent on research
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
2. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... If old age is a disease then ... With extensive research on HGH and stem cells technology, the ... perfected the art of rubbing off decades from your face ... with their revolutionary anti-aging hormone therapy and regenerative medicine. ... of youth, the MD of MetroMD, Dr Alex Martin said ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Today, Zane ... information on open enrollment for 2015. , According to ... coming up in November, employees are encouraged to start ... coverage in 2015, the open enrollment period will run ... open enrollment 2015 individuals can purchase a new individual ...
(Date:8/20/2014)... Boston, MA (PRWEB) August 20, 2014 ... the annual Inc. 500|5000 list; an exclusive list ranking ... this list are ranked according to their yearly percentage ... marks the 8th time on the Inc. 5000 list ... Experience Technology Company, Verndale offers its clients a wide ...
(Date:8/20/2014)... Oxnard dentist and noted ... Dental Art Institute, is presenting at the Spectrum Day ... speaking on All-on-4 dental implants in a ... Solutions” at 12:40 p.m. Sept. 20 at the Empire ... Canada. , “The All-on-4 procedure gives patients a set ...
(Date:8/20/2014)... No matter how “lonely” a person may be, he ... friends to be always there for them. However, it is ... making new friends during adulthood : not only is ... of one’s family to a near-slavish devotion to career-building, the ... just is not the same as it was when one ...
Breaking Medicine News(10 mins):Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... to leverage Health Integrated,s Synergy Targeted Population Management(R) ... for Medicaid subscribersPORTLAND, Ore. and TAMPA, Fla., March ... provides Medicaid and Medicare managed care services for ... Health Management company, are partnering to improve the ...
... Go Healthy, Inc. (Pink Sheets: GOHE) announced today that the ... Officer for the China Shenyang Company in support of the ... Loan Package.Stuart Evey, Chairman of Go Healthy and formerly the ... see the support of our operating plans and this letter ...
... control may improve neurologic outcomes after stroke or ... top-rated neurology programs cool their critically ill stroke ... and technologically advanced Arctic Sun(R) Temperature Management ... of the 30 top-ranked neurology programs at community ...
... market for further study. Now, after being formally approved for use ... Jersey cosmetic plastic surgeon discusses the reasons why the FDA’s decision ... ... (Vocus) March 25, 2009 -- New statistics from the ...
... awarded to one African-American student of high achievement. Ricky Williams is ... ... March 25, 2009 - Acupuncture & Massage College has established a ... African-American student of high achievement. The first recipient will be Ricky ...
... over several assisted reproduction cycles that use both fresh ... transferring two or more embryos at one time, according ... patients who choose to have only one embryo implanted ... The authors of the Finnish study published online today ...
Cached Medicine News:Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 3Health News:Go Healthy Announces Receipt of Letter of Interest to Fund Distribution, Production, Packaging, Concept Stores and Bottling Facilities 2Health News:Top Neurology Programs Control Fever with Arctic Sun Cooling Technology 2Health News:Top Neurology Programs Control Fever with Arctic Sun Cooling Technology 3Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 2Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 3Health News:As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants 4Health News:Acupuncture & Massage College Announces Ricky William's Scholarship 2Health News:Acupuncture & Massage College Announces Ricky William's Scholarship 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 2Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 4
(Date:8/19/2014)...  As power morcellator lawsuits continue to mount ... notes that women in need of fibroid removal ... options that do not involve the use of ... report published by The Wall Street Journal on ... mini-laparotomy and vaginal hysterectomy. Non-surgical options for shrinking ...
(Date:8/19/2014)... Aug. 19, 2014  Boehringer Ingelheim today announced ... accepted for review the New Drug Application (NDA) ... olodaterol delivered via the Respimat ® inhaler ... treatment of airflow obstruction in patients with chronic ... emphysema. Tiotropium + olodaterol FDC will not be ...
(Date:8/19/2014)...  SCILEX Pharmaceuticals, Inc., a company engaged in the ... treatment of pain, announced that it had formed a Scientific ... Gudin , Dr. Charles Argoff , Dr. ... SCILEX Chief Executive Officer Anthony ... greatly assist in the development and commercialization of future ...
Breaking Medicine Technology:As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4
... Aug, 24 BlueDot Medical, Inc. was named ... ranked #2,572 on the annual list of fastest ... among healthcare businesses. (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ... "We are extremely proud to see the ...
... Medical, Inc., the leader in examination and minor surgery ... emitting diode) to deliver higher illumination in a limited ... rooms.  The Super Exam 50 LED features the latest ... The 15-watt light source in the ...
Cached Medicine Technology:New Super Exam 50® LED from Burton Medical Provides the Most Positionable, High Intensity Diagnostic Light Available 2
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism....
Adult model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 14 mm....
Solid 14 mm blades, suture posts, and canthus bar. Dull finish....
... the E3671 twisted snare wires. The wire is ... the loop can be stopped at any point. ... loop can be slipped down the nerve before ... Comes with one package of E3671 twisted snare ...
Medicine Products: